Literature DB >> 23770282

Alterations in ryanodine receptors and related proteins in heart failure.

Sameer Ather1, Jonathan L Respress, Na Li, Xander H T Wehrens.   

Abstract

Sarcoplasmic reticulum (SR) Ca(2+) release plays an essential role in mediating cardiac myocyte contraction. Depolarization of the plasma membrane results in influx of Ca(2+) through l-type Ca(2+) channels (LTCCs) that in turn triggers efflux of Ca(2+) from the SR through ryanodine receptor type-2 channels (RyR2). This process known as Ca(2+)-induced Ca(2+)release (CICR) occurs within the dyadic region, where the adjacent transverse (T)-tubules and SR membranes allow RyR2 clusters to release SR Ca(2+) following Ca(2+) influx through adjacent LTCCs. SR Ca(2+) released during systole binds to troponin-C and initiates actin-myosin cross-bridging, leading to muscle contraction. During diastole, the cytosolic Ca(2+) concentration is restored by the resequestration of Ca(2+) into the SR by SR/ER Ca(2+)-ATPase (SERCA2a) and by the extrusion of Ca(2+) via the Na(+)/Ca(2+)-exchanger (NCX1). This whole process, entitled excitation-contraction (EC) coupling, is highly coordinated and determines the force of contraction, providing a link between the electrical and mechanical activities of cardiac muscle. In response to heart failure (HF), the heart undergoes maladaptive changes that result in depressed intracellular Ca(2+) cycling and decreased SR Ca(2+) concentrations. As a result, the amplitude of CICR is reduced resulting in less force production during EC coupling. In this review, we discuss the specific proteins that alter the regulation of Ca(2+) during HF. In particular, we will focus on defects in RyR2-mediated SR Ca(2+) release. This article is part of a Special Issue entitled: Heart failure pathogenesis and emerging diagnostic and therapeutic interventions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium; Contractility; Heart failure; Ryanodine receptor; Sarcoplasmic reticulum

Mesh:

Substances:

Year:  2013        PMID: 23770282      PMCID: PMC3800473          DOI: 10.1016/j.bbadis.2013.06.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  105 in total

1.  Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

Authors:  Sameer Ather; Wenyaw Chan; Biykem Bozkurt; David Aguilar; Kumudha Ramasubbu; Amit A Zachariah; Xander H T Wehrens; Anita Deswal
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

2.  Weighing in on heart failure: the role of SERCA2a SUMOylation.

Authors:  Robert J Schwartz; Edward T H Yeh
Journal:  Circ Res       Date:  2012-01-20       Impact factor: 17.367

3.  Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring.

Authors:  Donald M Bers
Journal:  Circ Res       Date:  2012-03-16       Impact factor: 17.367

4.  Action potential propagation in transverse-axial tubular system is impaired in heart failure.

Authors:  Leonardo Sacconi; Cecilia Ferrantini; Jacopo Lotti; Raffaele Coppini; Ping Yan; Leslie M Loew; Chiara Tesi; Elisabetta Cerbai; Corrado Poggesi; Francesco S Pavone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

5.  Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction.

Authors:  Hongyu Zhang; Catherine A Makarewich; Hajime Kubo; Wei Wang; Jason M Duran; Ying Li; Remus M Berretta; Walter J Koch; Xiongwen Chen; Erhe Gao; Héctor H Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

6.  Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Ting-Ting Hong; Rebecca Cogswell; Cynthia A James; Guson Kang; Clive R Pullinger; Mary J Malloy; John P Kane; Julianne Wojciak; Hugh Calkins; Melvin M Scheinman; Zian H Tseng; Peter Ganz; Teresa De Marco; Daniel P Judge; Robin M Shaw
Journal:  Heart Rhythm       Date:  2012-01-31       Impact factor: 6.343

7.  Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.

Authors:  Yu-Ping Xie; Biyi Chen; Philip Sanders; Ang Guo; Yue Li; Kathy Zimmerman; Lie-Cheng Wang; Robert M Weiss; Isabella M Grumbach; Mark E Anderson; Long-Sheng Song
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

8.  BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes.

Authors:  Ting-Ting Hong; James W Smyth; Kevin Y Chu; Jacob M Vogan; Tina S Fong; Brian C Jensen; Kun Fang; Marc K Halushka; Stuart D Russell; Henry Colecraft; Charles W Hoopes; Karen Ocorr; Neil C Chi; Robin M Shaw
Journal:  Heart Rhythm       Date:  2011-12-02       Impact factor: 6.343

Review 9.  Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Trends Cardiovasc Med       Date:  2011-02       Impact factor: 6.677

10.  SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway.

Authors:  Regalla Kumarswamy; Alexander R Lyon; Ingo Volkmann; Adam M Mills; Julia Bretthauer; Aanchal Pahuja; Cornelia Geers-Knörr; Theresia Kraft; Roger J Hajjar; Kenneth T Macleod; Sian E Harding; Thomas Thum
Journal:  Eur Heart J       Date:  2012-02-23       Impact factor: 29.983

View more
  24 in total

1.  A device for rapid and quantitative measurement of cardiac myocyte contractility.

Authors:  Angelo Gaitas; Ricky Malhotra; Tao Li; Todd Herron; José Jalife
Journal:  Rev Sci Instrum       Date:  2015-03       Impact factor: 1.523

Review 2.  Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

Authors:  Amanda L Denniss; Alexander M Dashwood; Peter Molenaar; Nicole A Beard
Journal:  Biophys Rev       Date:  2020-07-22

Review 3.  Novel drug targets in clinical development for heart failure.

Authors:  Melvin George; Muthukumar Rajaram; Elangovan Shanmugam; Thangavel Mahalingam VijayaKumar
Journal:  Eur J Clin Pharmacol       Date:  2014-04-09       Impact factor: 2.953

4.  Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2+ release.

Authors:  Julia O Reynolds; Ann P Quick; Qiongling Wang; David L Beavers; Leonne E Philippen; Jordan Showell; Giselle Barreto-Torres; Donna J Thuerauf; Shirin Doroudgar; Christopher C Glembotski; Xander H T Wehrens
Journal:  Int J Cardiol       Date:  2016-10-08       Impact factor: 4.164

Review 5.  The role of CaMKII in diabetic heart dysfunction.

Authors:  Lorna Daniels; James R Bell; Lea M D Delbridge; Fiona J McDonald; Regis R Lamberts; Jeffrey R Erickson
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

6.  Isoproterenol Promotes Rapid Ryanodine Receptor Movement to Bridging Integrator 1 (BIN1)-Organized Dyads.

Authors:  Ying Fu; Seiji A Shaw; Robert Naami; Caresse L Vuong; Wassim A Basheer; Xiuqing Guo; TingTing Hong
Journal:  Circulation       Date:  2016-01-05       Impact factor: 29.690

7.  Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy.

Authors:  Estibaliz Castillero; Hirokazu Akashi; Klara Pendrak; Halit Yerebakan; Marc Najjar; Catherine Wang; Yoshifumi Naka; Donna Mancini; H Lee Sweeney; Jeanine D Armiento; Ziad A Ali; P Christian Schulze; Isaac George
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-08       Impact factor: 4.733

8.  Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease.

Authors:  Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

9.  Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.

Authors:  Michael T Massengill; Hassan M Ashraf; Rajib R Chowdhury; Stephen M Chrzanowski; Jeena Kar; Sonisha A Warren; Glenn A Walter; Huadong Zeng; Byung-Ho Kang; Robert H Anderson; Richard L Moss; Hideko Kasahara
Journal:  Cardiovasc Res       Date:  2016-03-29       Impact factor: 10.787

10.  Reduced junctional Na+/Ca2+-exchanger activity contributes to sarcoplasmic reticulum Ca2+ leak in junctophilin-2-deficient mice.

Authors:  Wei Wang; Andrew P Landstrom; Qiongling Wang; Michelle L Munro; David Beavers; Michael J Ackerman; Christian Soeller; Xander H T Wehrens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.